BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35129738)

  • 1. Cost and Utilization Impacts of a Medicaid Managed Care Organization's Behavioral Health Wraparound Program.
    Chi W; Nguyen BT; Kent ST; Sylwestrzak G
    Adm Policy Ment Health; 2022 Jul; 49(4):658-669. PubMed ID: 35129738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost and utilization of behavioral health medications associated with rescission of an exemption for prior authorization for severe and persistent mental illness in the Vermont Medicaid Program.
    Simeone JC; Marcoux RM; Quilliam BJ
    J Manag Care Pharm; 2010 Jun; 16(5):317-28. PubMed ID: 20518584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impacts of an Integrated Medicaid Managed Care Program for Adults with Behavioral Health Conditions: The Experience of Illinois.
    Xiang X; Owen R; Langi FLFG; Yamaki K; Mitchell D; Heller T; Karmarkar A; French D; Jordan N
    Adm Policy Ment Health; 2019 Jan; 46(1):44-53. PubMed ID: 30171393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost and utilization analysis of a pediatric emergency department diversion project.
    Wang C; Villar ME; Mulligan DA; Hansen T
    Pediatrics; 2005 Nov; 116(5):1075-9. PubMed ID: 16263992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic and utilization outcomes of medication management at a large Medicaid plan with disease management pharmacists using a novel artificial intelligence platform from 2018 to 2019: a retrospective observational study using regression methods.
    Kessler S; Desai M; McConnell W; Jai EM; Mebine P; Nguyen J; Kiroyan C; Ho D; Von Schweber E; Von Schweber L
    J Manag Care Spec Pharm; 2021 Sep; 27(9):1186-1196. PubMed ID: 34032130
    [No Abstract]   [Full Text] [Related]  

  • 6. Managed care for the Medicaid disabled: effect on utilization and costs.
    Cebul RD; Solti I; Gordon NH; Singer ME; Payne SM; Gharrity KA
    J Urban Health; 2000 Dec; 77(4):603-24. PubMed ID: 11194305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expenditures and use of wraparound health insurance for employed people with disabilities.
    Gettens J; Hoffman D; Henry AD
    Disabil Health J; 2016 Apr; 9(2):248-55. PubMed ID: 26781193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impacts of a Medicaid Wraparound Model Demonstration Program on Youth Specialty Mental Health Services Use.
    Blizzard AM; Glos LJ; Stephan SH; Medoff D; Slade EP
    J Behav Health Serv Res; 2017 Jul; 44(3):373-385. PubMed ID: 27306371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pennsylvania's Medical Home Initiative: Reductions in Healthcare Utilization and Cost Among Medicaid Patients with Medicaland Psychiatric Comorbidities.
    Rhodes KV; Basseyn S; Gallop R; Noll E; Rothbard A; Crits-Christoph P
    J Gen Intern Med; 2016 Nov; 31(11):1373-1381. PubMed ID: 27353455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of copayments with healthcare utilization and expenditures among Medicaid enrollees with a substance use disorder.
    Lazic A; Tilford JM; Davis VP; Brown CC
    J Subst Use Addict Treat; 2024 Jun; 161():209314. PubMed ID: 38369244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pursuing cost-effectiveness in mental health service delivery for youth with complex needs.
    Grimes KE; Schulz MF; Cohen SA; Mullin BO; Lehar SE; Tien S
    J Ment Health Policy Econ; 2011 Jun; 14(2):73-83. PubMed ID: 21881163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in outpatient mental health service utilization under capitation.
    Chou AF; Wallace N; Bloom JR; Hu TW
    J Ment Health Policy Econ; 2005 Mar; 8(1):3-14. PubMed ID: 15870481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicaid Cost Trajectories for Children With Serious Emotional Disturbance: The HCBS Waiver Program Versus Targeted Case Management.
    Frimpong EY; Kuang J; Wang R; Radigan M
    Psychiatr Serv; 2018 Nov; 69(11):1160-1166. PubMed ID: 30152274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization and costs for children who have special health care needs and are enrolled in a hospital-based comprehensive primary care clinic.
    Berman S; Rannie M; Moore L; Elias E; Dryer LJ; Jones MD
    Pediatrics; 2005 Jun; 115(6):e637-42. PubMed ID: 15930189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National and regional description of healthcare measures among adult Medicaid beneficiaries with schizophrenia within the United States.
    Patel C; Pilon D; Gupta D; Morrison L; Lafeuille MH; Lefebvre P; Benson C
    J Med Econ; 2022; 25(1):792-807. PubMed ID: 35635250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective Care Management for Children With Special Health Care Needs in the Era of Value-Based Payment.
    Weiss MA; Marchese S; Zhang L
    Clin Pediatr (Phila); 2019 Aug; 58(9):949-956. PubMed ID: 30924371
    [No Abstract]   [Full Text] [Related]  

  • 17. Health care utilization by children with chronic illnesses: a comparison of medicaid and employer-insured managed care.
    Shatin D; Levin R; Ireys HT; Haller V
    Pediatrics; 1998 Oct; 102(4):E44. PubMed ID: 9755281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of behavioral health integration in Medicaid managed care on access to mental health and primary care services-Evidence from early adopters.
    McConnell KJ; Edelstein S; Hall J; Levy A; Danna M; Cohen DJ; Lindner S; Unützer J; Zhu JM
    Health Serv Res; 2023 Jun; 58(3):622-633. PubMed ID: 36635871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Intervention for High-Need, High-Cost Medicaid Patients: a Study of ECHO Care.
    Komaromy M; Bartlett J; Gonzales-van Horn SR; Zurawski A; Kalishman SG; Zhu Y; Davis HT; Ceballos V; Sun X; Jurado M; Page K; Hamblin A; Arora S
    J Gen Intern Med; 2020 Jan; 35(1):21-27. PubMed ID: 31667743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community Asthma Initiative: Cost Analyses using Claims Data from a Medicaid Managed Care Organization.
    Bhaumik U; Sommer SJ; Lockridge R; Penzias R; Nethersole S; Woods ER
    J Asthma; 2020 Mar; 57(3):286-294. PubMed ID: 30663906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.